BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31131539)

  • 1. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway.
    Wang X; Pan J; Liu D; Zhang M; Li X; Tian J; Liu M; Jin T; An F
    J Cell Mol Med; 2019 Aug; 23(8):5349-5359. PubMed ID: 31131539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENDOGENOUS β 3 -ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY.
    Xing Y; Tian T; Zhang X; Yang D; Zhang C; Wang M; Wang Y; Luo T; Wang Z; Wang H; Li H
    Shock; 2024 Jun; 61(6):915-923. PubMed ID: 38662592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of Macrostemonoside T from Allium macrostemon Bunge against Isoproterenol-Induced myocardial injury via the PI3K/Akt/mTOR signaling pathway.
    Wu J; Cui Y; Ding W; Zhang J; Wang L
    Int Immunopharmacol; 2024 May; 133():112086. PubMed ID: 38642441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
    Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
    Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin Ameliorates Myocardial Injury in Diabetic Rats by Regulating Autophagy and Apoptosis through AMPK/mTOR Signaling Pathway.
    Chen YF; Qiu Q; Wang L; Li XR; Zhou S; Wang H; Jiang WD; Geng JY; Qin-Gao ; Tang B; Wang HJ; Kang PF
    Am J Chin Med; 2024; 52(3):841-864. PubMed ID: 38716618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K/AKT pathway.
    Wang F; Wang J; Liang X; Wu Z; Xue J; Yin L; Wei L; Zhang X
    J Drug Target; 2024 Dec; 32(2):148-158. PubMed ID: 38088811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway.
    Geng H; Zhang H; Cheng L; Dong S
    Int Immunopharmacol; 2024 Feb; 128():111466. PubMed ID: 38176345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.
    Zhang X; Qu L; Chen L; Chen C
    Physiol Rep; 2018 Feb; 6(4):. PubMed ID: 29446246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.
    Alobaid SM; Alshahrani RM; Alonazi AS; Alrasheed NM; Alamin MA; Alshammari TK; Bin Dayel AF; Elnagar DM; Alotaibi RR; Almuthnabi LA; Almasud DH; Al-Ammar SE; Almadhi SO; Almalke RA; Aldamri NT; Alghibiwi HK; Alkhelb DA; Alrasheed NM
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum in: Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):12. PubMed ID: 38709526
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to Associations between the polymorphisms of main components in PI3K/Akt pathway and risk of diabetic kidney disease: A meta-analysis.
    IUBMB Life; 2024 Feb; 76(2):103. PubMed ID: 37650586
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy.
    Zhang M; Wang X; Liu M; Liu D; Pan J; Tian J; Jin T; Xu Y; An F
    J Cell Mol Med; 2020 Apr; 24(8):4612-4623. PubMed ID: 32150791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
    Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
    Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicorandil combats doxorubicin-induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway.
    Khames A; Khalaf MM; Gad AM; Abd El-Raouf OM; Kandeil MA
    Chem Biol Interact; 2019 Sep; 311():108777. PubMed ID: 31376360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways.
    Ren BC; Zhang YF; Liu SS; Cheng XJ; Yang X; Cui XG; Zhao XR; Zhao H; Hao MF; Li MD; Tie YY; Qu L; Li XY
    J Cell Mol Med; 2020 Nov; 24(21):12355-12367. PubMed ID: 32961025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis.
    Liu D; Wang X; Zhang M; Tian J; Liu M; Jin T; Pan J; Gao M; An F
    J Cell Mol Med; 2020 Oct; 24(20):11729-11741. PubMed ID: 32851768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.
    Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z
    Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis.
    Ge Q; Zhao L; Ren XM; Ye P; Hu ZY
    Exp Biol Med (Maywood); 2019 Sep; 244(12):1028-1039. PubMed ID: 31262190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.